ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
ResMed (RMD) Reports In-Line Q4 EPS, Revenues Slightly Beat
August 2, 2018 4:36 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $0.95, in-line with the analyst estimate of $0.95. Revenue for the quarter came in at $623.6 million versus the consensus estimate of $623.2 million.
Revenue increased 12% to $623.6 million; up 10% on a constant currency basisNet income increased by 8%; non-GAAP net income up... More
